Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells

The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2020
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://ncbi.nlm.nih.gov/pubmed/32934745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12039
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi